Hawitt Pharmaceuticals Private Limited
About Hawitt Pharmaceuticals Private Limited
Data last updated:
Hawitt Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 February 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2016PTC049255. Its GSTIN is 08AADCH8052K1ZB (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Choudhary and Aneesh Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No. 229 Shop No. 2 First Floor Above Mehta Kirana & General Store Near Indu Motors, Jaipur, Rajasthan, India – 302012.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.48 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹2.84 Lakh (net margin 1.9%) and EBITDA of ₹4.11 Lakh (EBITDA margin 2.8%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 28% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Hawitt Pharmaceuticals Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhasra No. 229 Shop No. 2 First Floor Above Mehta Kirana & General Store Near Indu Motors, Jaipur, Rajasthan, India – 302012
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hawitt Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hawitt Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hawitt Pharmaceuticals Private Limited, buy the company report.
Financials of Hawitt Pharmaceuticals Private Limited
FY 2025 filings availableHawitt Pharmaceuticals Private Limited reported revenue of ₹1.48 Cr (up 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 28% over five years, including 31% growth in the latest year. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.84 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hawitt Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hawitt Pharmaceuticals Private Limited
Hawitt Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajesh Choudhary | Director | 10 Feb 2016 | 10 Years 8 Months | Current |
| Aneesh Sharma | Director | 10 Oct 2016 | 10 Years 0 Months | Current |
Peer comparison
Hawitt Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mensun Pharmaceuticals Private Limited | ₹1.49 Cr (FY 2025) | 0.0% | New Delhi, Delhi, India | |||
| Meclon Pharmaceuticals Private Limited | ₹1.49 Cr (FY 2023) | 210.0% | Bangalore, Karnataka, India | |||
| Actiff Pharmaceuticals Private Limited | ₹1.48 Cr (FY 2019) | 31.0% | Nallasopara West, Maharashtra, India | |||
| Hawitt Pharmaceuticals Private Limitedthis company | ₹1.48 Cr (FY 2025) | ₹2.84 Lakh | 1.9% | 31.0% | Jaipur, Rajasthan, India | |
| Isocratic Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | Ahmedabad, Gujarat, India | ||||
| Strimed Pharmaceuticals Private Limited | ₹1.47 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Hawitt Pharmaceuticals Private Limited, buy the company report.
Auditor
Hawitt Pharmaceuticals Private Limited is audited by KUMAWAT & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KUMAWAT & ASSOCIATES | FY 2023 | 016854C |
Shareholding
The shareholding of Hawitt Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Hawitt Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hawitt Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hawitt Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Hawitt Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCH8052K1ZB | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Hawitt Pharmaceuticals Private Limited, buy the company report.
Recent activity
Hawitt Pharmaceuticals Private Limited has 4 board changes on record since 2016: 3 appointments and 1 cessation. The latest: Ashish Kumar Kumawat ceased to be Director on 02 Mar 2018.
Frequently asked questions
Hawitt Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 February 2016 (10+ years old) and is registered under CIN U24232RJ2016PTC049255.
Hawitt Pharmaceuticals has 2 current directors:
- Rajesh Choudhary - Director
- Aneesh Sharma - Director
The latest financial statements of Hawitt Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Hawitt Pharmaceuticals is 08AADCH8052K1ZB, registered in Rajasthan.
The CIN (Corporate Identification Number) of Hawitt Pharmaceuticals is U24232RJ2016PTC049255. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hawitt Pharmaceuticals was incorporated on 10 February 2016, making it 10+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Hawitt Pharmaceuticals by revenue are Mensun Pharmaceuticals Private Limited, Meclon Pharmaceuticals Private Limited, Actiff Pharmaceuticals Private Limited, Isocratic Pharmaceuticals Private Limited, Strimed Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ashish Kumar Kumawat ceased to be Director on 02 Mar 2018. Aneesh Sharma was appointed as Director on 10 Oct 2016. Ashish Kumar Kumawat was appointed as Director on 10 Feb 2016. Hawitt Pharmaceuticals has 4 board changes on record in total.
The registered office of Hawitt Pharmaceuticals is at Khasra No. 229 Shop No. 2 First Floor Above Mehta Kirana & General Store Near Indu Motors, Jaipur, Rajasthan, India – 302012.
Hawitt Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Hawitt Pharmaceuticals is compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
